News Release

No link between acid reflux and survival

Heartburn sufferers need not live in fear

Peer-Reviewed Publication

Blackwell Publishing Ltd.

Rochester, Minn. – January 03, 2007 - Gastroesophageal reflux disease (GERD), often known as acid reflux, is a common problem that has been associated with cancers, asthma, recurrent aspiration and pulmonary fibrosis. A new study published in The American Journal of Gastroenterology examines whether GERD sufferers may have shorter lifespans than those without the disease.

Drawing on over 50,000 person-years of data, the study provides reassuring evidence that people with acid reflux symptoms do not have an increased risk of death, finding no difference in survival rates between sufferers and non-sufferers.

In fact, the study finds that people with infrequent acid reflux may actually have better survival rates than those with either daily symptoms, or none at all. “It may be that occasional reflux symptoms are a reflection of potential protective behaviors that are associated with reflux, such as regular exercise or modest amounts of alcohol ingestion,” suggest Nicholas J. Talley and G. Richard Locke, III, co-authors of the study.

The study adds perspective to the risk of acid reflux symptoms. While there are a large number of acid reflux sufferers in the U.S., incidences of related cancer are extremely rare. “Although extraesophageal manifestations occur in some people with reflux disease, our results suggest that this disease is a benign condition in the vast majority of sufferers,” say the authors.

###

This study is published in The American Journal of Gastroenterology. Media wishing to receive a PDF of this article may contact medicalnews@bos.blackwellpublishing.net.

Nicholas J. Talley, M.D., Ph.D., is Editor-in-Chief of The American Journal of Gastroenterology; a Professor of Medicine and Epidemiology at the Mayo Clinic College of Medicine; and Chair of the Department of Internal Medicine at the Mayo Clinic, Jacksonville.

G. Richard Locke, III, M.D., is a Professor of Medicine at the Mayo Clinic College of Medicine; Consultant, Division of Gastroenterology and Hepatology, Department of Internal Medicine; and Consultant, Division of Health Care Policy & Research, Department of Health Sciences Research at the Mayo Clinic.

To reach Drs. Talley or Locke for interview, please contact Elizabeth Rice of the Mayo Clinic Department of Public Affairs at newsbureau@mayo.edu or 507-284-5005.

The American College of Gastroenterology (ACG) was founded in 1932 to advance the scientific study and medical practice of diseases of the gastrointestinal (GI) tract. The College promotes the highest standards in medical education and is guided by its commitment to meeting the individual and collective needs of clinical GI practitioners. For more information, please visit www.acg.gi.org.

The American Journal of Gastroenterology is the official publication of the American College of Gastroenterology, and the #1 clinical journal in gastroenterology. The journal brings a broad-based, interdisciplinary approach to the study of gastroenterology, including articles reporting on current observations, research results, methods of treatment, drugs, epidemiology, and other topics relevant to clinical gastroenterology. For more information, please visit www.blackwellpublishing.com/ajg.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.